Please Share this link to POI’s Free Newsletter
Join POI’s Search Engine Registration Now Free. Please Share Link
Great Newsin Israel on The Medical Front
Once-a-day injection to treat Parkinson’s. Israel’s Pharma Two B (see here previously) is presenting the full results of its Phase 3 trial of its once-a-day injection of its P2B001 treatment for Parkinson’s disease. P2B001 combines low-dose pramipexole with low-dose rasagiline. It relieves PD symptoms with few side effects.
Sheba implements fast cancer diagnosis. Sheba Medical Center has deployed a new accelerated, AI-powered cancer diagnostics research platform to improve patient diagnosis, treatment, and outcomes. It utilizes solutions of various Israeli startups, including that of Imagene (see here previously).
Shalom Rafael Haar Founder